Home
Scholarly Works
Comparing FEIBA with recombinant FVIIA for...
Conference

Comparing FEIBA with recombinant FVIIA for reversal of rivaroxaban with a modified anti-Xa assay in undiluted Plasma

Authors

Gantioqui J; Stevic I; Lee F; Chan A; Chan H

Volume

13

Pagination

pp. 389-389

Publisher

WILEY-BLACKWELL

Publication Date

June 1, 2015

Conference proceedings

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

ISSN

1538-7933

Contact the Experts team